Commerzbank Aktiengesellschaft’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,881
Closed -$252K 361
2025
Q2
$252K Buy
+2,881
New +$226K 0.01% 318
2025
Q1
Sell
-2,881
Closed -$225K 353
2024
Q4
$225K Buy
+2,881
New +$213K 0.01% 313
2024
Q3
Sell
-1,791
Closed -$204K 308
2024
Q2
$204K Sell
1,791
-287
-14% -$36.3K 0.01% 238
2024
Q1
$289K Buy
2,078
+463
+29% +$58.2K 0.01% 206
2023
Q4
$201K Buy
+1,615
New +$165K 0.01% 200
2017
Q2
Sell
-15,088
Closed -$320K 761
2017
Q1
$320K Buy
+15,088
New +$294K ﹤0.01% 769

Other funds holding DXCM

Commerzbank Aktiengesellschaft's DXCM Position: Q3 2025 in Review

Commerzbank Aktiengesellschaft sold out of DexCom (DXCM) in Q3 2025, closing a stake of 2,881 shares — an estimated $252K sold.

Commerzbank Aktiengesellschaft first reported a position in DXCM in Q1 2017 and held it in 6 quarters. The position peaked at $320K in Q1 2017. 911 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • Commerzbank Aktiengesellschaft reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 2,881 DexCom shares in Q3 2025, an estimated $252K.
  • Commerzbank Aktiengesellschaft first reported a position in DexCom in Q1 2017 and held it in 6 quarters.
  • Commerzbank Aktiengesellschaft's DexCom position peaked at $320K in Q1 2017.
  • 911 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q3 2025, filed 31 Oct 2025.